Merck

Targeting the histidine pathway in Mycobacterium tuberculosis.

Current topics in medicinal chemistry (2013-10-12)
Juleane Lunardi, José Eduardo S Nunes, Cristiano V Bizarro, Luiz Augusto Basso, Diógenes Santiago Santos, Pablo Machado
摘要

Worldwide, tuberculosis is the leading cause of morbidity and mortality due to a single bacterial pathogen, Mycobacterium tuberculosis (Mtb). The increasing prevalence of this disease, the emergence of multi-, extensively, and totally drug-resistant strains, complicated by co-infection with the human immunodeficiency virus, and the length of tuberculosis chemotherapy have led to an urgent and continued need for the development of new and more effective antitubercular drugs. Within this context, the L-histidine biosynthetic pathway, which converts 5-phosphoribosyl 1-pyrophosphate to L-histidine in ten enzymatic steps, has been reported as a promising target of antimicrobial agents. This pathway is found in bacteria, archaebacteria, lower eukaryotes, and plants but is absent in mammals, making these enzymes highly attractive targets for the drug design of new antimycobacterial compounds with selective toxicity. Moreover, the biosynthesis of L-histidine has been described as essential for Mtb growth in vitro. Accordingly, a comprehensive overview of Mycobacterium tuberculosis histidine pathway enzymes as attractive targets for the development of new antimycobacterial agents is provided, mainly summarizing the previously reported inhibition data for Mtb or orthologous proteins.

材料
货号
品牌
产品描述

Sigma-Aldrich
L-组氨酸, ReagentPlus®, ≥99% (TLC)
Sigma-Aldrich
L-组氨酸, suitable for cell culture, meets EP, USP testing specifications, from non-animal source
SAFC
L-组氨酸
Sigma-Aldrich
L-组氨酸, BioUltra, ≥99.5% (NT)
组氨酸, European Pharmacopoeia (EP) Reference Standard
Supelco
L-组氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-组氨酸, certified reference material, TraceCERT®